Pharmaceutical company Eli Lilly announced promising clinical trial results for a daily pill to treat obesity and diabetes, a considerable advantage over other GLP-1-based weight-loss drugs that have to be injected on a weekly basis. But besides showing no overly concerning side effects and allowing trial participants to lose an average of 16 pounds over almost ten months, the pill has an extremely unfortunate quality: its name. Eli Lilly chose to name its new drug "orforglipron," a word so perplexingly — and frustratingly — unpronounceable, it defies belief. According to the company, it's pronounced "or-for-GLIP-ron," which somehow makes the moniker […]

---

Link :
https://futurism.com/neoscope/eli-lillys-new-weight-loss-drug-worst-name